Digest Network Come funziona
Network
/
Società
Be
Non verificato

BeOne Medicines Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

46 comunicati stampa

Guarda tutti i comunicati
12/06/2026
Eventi
Industria
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
11/06/2026
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
01/06/2026
Web e Social Network
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
29/05/2026
Eventi
Industria
Scienza
Igiene alimentare
Medicina - Varie
Cardiologia
Biotecnologia
Salute
Farmaceutica
Oncologia
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
27/05/2026
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Sanità
Farmaceutica
Salute
Oncologia
Eventi
Industria
BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
26/05/2026
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
Eventi
Web e Social Network
BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
21/05/2026
Web e Social Network
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
20/05/2026
BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
13/05/2026
BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0
29/04/2026
Industria
Oncologia
Igiene alimentare
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
Fonte
BeOne Medicines Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0